Physical Examination-Indicated Pessary

Sponsor
Federico II University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02967445
Collaborator
(none)
0
1
2
15.9
0

Study Details

Study Description

Brief Summary

Cervical insufficiency, previously referred to as cervical incompetence, has classically been defined as painless dilation of the cervix in the absence of contractions or bleeding in the second trimester resulting in recurrent pregnancy losses. Painless mid-trimester cervical dilation is an uncommon finding in the general population occurring in less than 1% of pregnancies. Cerclage for the prevention pregnancy loss in cases with both prior preterm births and/or second trimester losses, as well as second trimester cervical dilatation in the index pregnancy, was first reported in the 1950's. Cerclage placement in this setting has been variably referred to as "physical exam-indicated cerclage", "rescue cerclage", and "emergency cerclage". To date, the benefits of cerclage for this indication are not entirely clear.

A recent meta-analysis showed that physical exam-indicated cerclage is associated with a reduction in perinatal mortality and prolongation of pregnancy when compared to no such cerclage.

Recently, several RCTs have shown that cervical pessary could decrease the incidence of PTB in several populations.

Thus, the aim of our trial as noninferiority trial is to evaluate the efficacy of pessary compared to cervical cerclage in prevention of PTB in women in the setting of mid-trimester cervical dilation

Condition or Disease Intervention/Treatment Phase
  • Device: Arabin Pessary
  • Device: Cervical cerclage
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Actual Study Start Date :
Nov 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2017
Anticipated Study Completion Date :
Mar 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cervical pessary

Arabin Pessary

Device: Arabin Pessary
Arabin silicon pessary

Active Comparator: Cervical cerclage

McDonald Cerclage

Device: Cervical cerclage

Outcome Measures

Primary Outcome Measures

  1. Neonatal survival [From delivery to 28 days]

Secondary Outcome Measures

  1. Preterm birth [time of delivery]

    <24, <28, <30 weeks. both spontaneous and indicated

  2. Latency [time of delivery]

    Time from randomization to delivery

  3. Birth weight [time of delivery]

    in grams

  4. gestational age at delivery [time of delivery]

    mean of delivery

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Singleton pregnancies

  • Cervical dilation between 1 to 5 cm and/or visible membranes by pelvic exam or speculum exam between at 16-23 6/7 weeks gestation

Exclusion Criteria:
  • Pessary or cerclage already in situ

  • active vaginal bleeding

  • Placenta previa/accreta

  • Multiple gestations

  • Amniotic membranes prolapsed beyond external os into the vagina, unable to visualize cervical tissue

  • Ruptured amniotic membranes at the time of diagnosis of dilated cervix

  • Cervical dilation more than 5 cm

  • Labor (progressing cervical dilation) or painful regular uterine contractions

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gabriele Saccone Napoli Italy 80129

Sponsors and Collaborators

  • Federico II University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gabriele Saccone, MD, Federico II University
ClinicalTrials.gov Identifier:
NCT02967445
Other Study ID Numbers:
  • 2156/15
First Posted:
Nov 18, 2016
Last Update Posted:
Nov 19, 2018
Last Verified:
Nov 1, 2018
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 19, 2018